Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T02:40:08.748Z Has data issue: false hasContentIssue false
  • English
  • Français

Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study

Published online by Cambridge University Press:  10 May 2016

Daniel J. Diekema ,
Sandra S. Richter ,
Kristopher P. Heilmann ,
Cassie L. Dohrn ,
Fathollah Riahi ,
Shailesh Tendolkar ,
Jennifer S. McDanel  and
Gary V. Doern
Daniel J. Diekema*
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa
Sandra S. Richter
Affiliation:
Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio
Kristopher P. Heilmann
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Cassie L. Dohrn
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Fathollah Riahi
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Shailesh Tendolkar
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Jennifer S. McDanel
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
Gary V. Doern
Affiliation:
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa
*
200 Hawkins Drive, Iowa City, IA 52246 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is changing, with USA300 emerging first in community and then in healthcare settings. We performed nationwide surveillance to assess recent trends in the molecular epidemiology of MRSA.

Methods.

One hundred consecutive unique clinically significant S. aureus isolates were recovered from patients at each of 43 US centers between July 1, 2011, and December 31, 2011. Susceptibility testing, pulsed-field gel electrophoresis (PFGE), staphylococcal protein A gene (spa) and staphylococcal cassette chromosome mec typing, and Panton-Valentine leukocidin detection were performed on all MRSA isolates.

Results.

Of 4,131 isolates collected, 2,093 (51%) were MRSA. Specimen sources of MRSA isolates included wound or abscess (54%), blood (24%), lower respiratory tract (11%), and other sterile site (10%). Thirty percent were isolated more than 48 hours after hospital admission (ie, were associated with nosocomial acquisition of infection). USA300 was the most common PFGE type (1,269 isolates; 61%), overall and in all regions, followed by USA100 (368 isolates; 18%). Among 173 spa types found, the most common were t008 (51%) and t002 (18%); no other spa type accounted for more than 2% of isolates. One strain type (USA300/t008/IV) constituted almost half of all MRSA isolates (1,005 isolates; 48%) and was the most common at all body sites, causing 37% of MRSA bloodstream infections (BSIs) and 38% of nosocomial MRSA infections. Multidrug-resistant phenotypes were found among 34 USA300 isolates (3%) from 18 states.

Conclusions.

The USA300 PFGE type continues to advance nationwide. A single strain type (USA300/t008/IV) predominates in all regions and infection sites and is now more common than USA 100 as a cause of MRSA BSI and nosocomial infections. Although most USA300 retain typical susceptibility profiles, multidrug-resistant phenotypes are emerging.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 3 , March 2014 , pp. 285 - 292
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Diekema, DJ, Pfaller, MA, Schmitz, FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program 1997-1999. Clin Infect Dis 2001;32(S2):S114–S132.Google Scholar
2. Liu, C, Bayer, A, Cosgrove, SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of MRSA infections in adults and children. Clin Infect Dis 2011; 52:285–292.Google Scholar
3. Chambers, HF, Deleo, FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629–641.Google Scholar
4. McDougal, LK, Steward, CD, Killgore, GE, Chaitram, JM, McAllister, SK, Tenover, FC. Pulsed field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113–5120.Google Scholar
5. McDougal, LK, Fosheim, GE, Nicholson, A, et al. Emergence of resistance among USA300 MRSA isolates causing invasive disease in the United States. Anumiaob Agents Chemother 2010; 54:3804–3811.Google Scholar
6. Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al. MRSA infections among patients in the emergency department. N Engl J Med 2006;355:666–674.Google Scholar
7. Klevens, RM, Morrison, MA, Nadle, J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298;1763–1771.Google Scholar
8. Popovich, KJ, Weinstein, RA, Hota, B. Are community-associated MRSA replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008;46:787–794.Google Scholar
9. Centers for Disease Control and Prevention, http://wvw.cdc.gov/abcs/reports-findings/survreports/mrsa11.pdf. Accessed July 20, 2013.Google Scholar
10. Kallen, AJ, Mu, Y, Bulens, S, et al. Healthcare-associated invasive MRSA infections, 2005-2008. JAMA 2010;304:641–648.Google Scholar
11. D'Agata, EM, Webb, GF, Horn, MA, et al. Modeling the invasion of community-acquired MRSA into hospitals. Clin Infect Dis 2009;48:274–284.CrossRefGoogle ScholarPubMed
12. Kouyos, R, Klein, E, Grenfell, B. Hospital-community interactions foster co-existence between methicillin-resistant strains of Staphylococcus aureus . PLOS Pathog 2013;9(2):el003134.Google Scholar
13. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, Eighth Edition. CLSI document M7-A9. Wayne, PA: CLSI, 2012.Google Scholar
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing 22nd Informational Supplement. CLSI document M100-S22. Wayne, PA: CLSI, 2012.Google Scholar
15. Oliveira, DC, de Lencastré, H. Multiplex strategy for rapid identification of structural types and variants of the mec element in MRSA. Antimicrob Agents Chemother 2002;46:2155–2161.Google Scholar
16. Pfaller, MA, Caliendo, AM, Versalovic, J. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis: application to molecular epidemiology. In: Garcia, LS, ed. Clinical Microbiology Procedures Handbook, Third Edition. Washington, DC: ASM, 2010.Google Scholar
17. Shopsin, B, Gomez, M, Montgomery, S, et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Mkrobiol 1999;37:3556–3563.CrossRefGoogle ScholarPubMed
18. Talan, DA, Krishnadasan, A, Gorwitz, RJ, et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in U.S. emergency department patients, 2004 and 2008. Clin Infect Dis 2011;53:144–149.Google Scholar
19. Richter, SS, Heilmann, KP, Dohm, CL, et al. Activity of ceftaroline and epidemiologic characterization of Staphylococcus aureus from 43 medical centers in the United States, 2009. Antimicrob Agents Chemother 2011;55:4154–4160.Google Scholar
20. Hudson, LO, Murphy, CR, Spratt, BG, et al. Diversity of MRSA strains isolated from inpatients of 30 hospitals in Orange County, California. PLOS ONE 2013;8(4):e62117.Google Scholar
21. Tenover, FC, Tickler, IA, Goering, RV, et al. Characterization of nasal and blood culture isolates of MRSA from patients in US hospitals. Antimicrob Agents Chemother 2012;1324–1230.CrossRefGoogle Scholar
22. Ender, M, McCallum, N, Adhikari, et al. 2004. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus . Antimicrob Agents Chemother 48:2295–2297.Google Scholar
23. Lee, SM, Ender, M, Adhikari, R, et al. Fitness cost of staphylococcal cassette chromosome mec in MRSA by way of continuous culture. Antimicrob Agents Chemother 2007;51:1497–1499.Google Scholar
24. Huang, SS, Septimus, E, Kleinman, K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013;368;2255–2265.CrossRefGoogle ScholarPubMed
25. Kempker, RR, Farley, MM, Ladson, JL, et al. Association of MRSA USA300 genotype with mortality in MRSA bacteremia. J Infect 2010;61:372–381.Google Scholar
26. Kreisel, KM, Stine, OC, Johnson, JK, et al. USA300 MRSA bacteremia and the risk of severe sepsis: is USA300 MRSA associated with more severe infections? Diagn Microbiol Infect Dis 2011;70: 285–290.Google Scholar
27. Lalani, T, Federspiel, JJ, Boucher, HW, et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 2008;46:2890–2896.CrossRefGoogle ScholarPubMed
28. Wibbenmeyer, LA, Kealey, GP, Latenser, BA, et al. Emergence of the USA300 strain of MRSA in a burn-trauma unit. J Burn Care Res 2008;29:790–797.Google Scholar